8-KLeadership ChangesExhibits & Filings

CELESTICA INC 8-K Report, Executive Changes (Dec 5, 2025)

Filed December 5, 2025For Securities:CLS

Summary

Celestica Inc. (CLS) has announced a significant change in its Board of Directors, with Dr. Luis Müller intending to resign effective January 28, 2026. Dr. Müller is stepping down from his roles as a Director, Chair of the Audit Committee, and member of other Board committees. The company explicitly states that his departure is for personal reasons to pursue other professional commitments and is not a result of any disagreements concerning the Company's operations, policies, or practices. Dr. Müller will continue to fulfill his duties fully until his resignation date, ensuring a smooth transition. In anticipation of Dr. Müller's departure, the Board has appointed Mr. Amar Maletira, a current Board member, to succeed him as Chair of the Audit Committee. Mr. Maletira brings extensive financial leadership experience, including over 25 years in public company business and strategic finance roles within the enterprise technology sector, notably holding Chief Financial Officer positions. The Board has confirmed his financial expertise makes him well-suited for this critical role, indicating a stable leadership transition for the Audit Committee.

Key Highlights

  • 1Dr. Luis Müller to resign from Celestica's Board of Directors, Audit Committee Chair, and other committees, effective January 28, 2026.
  • 2Dr. Müller's resignation is due to personal reasons and other professional commitments, with no disagreement with the Company.
  • 3Dr. Müller will remain actively engaged in his current capacities until his resignation.
  • 4Mr. Amar Maletira, a current Board member, appointed as the new Chair of the Audit Committee, effective January 28, 2026.
  • 5Mr. Maletira possesses over 25 years of financial leadership experience, including CFO roles in technology industries.
  • 6The Board has determined Mr. Maletira has the necessary financial expertise for the Audit Committee Chair role.

Frequently Asked Questions

Dr. Müller is resigning for personal reasons to focus on other professional commitments. The Company has stated that his decision is not due to any disagreement with Celestica Inc. regarding its operations, policies, or practices.

Dr. Müller's resignation will be effective at the conclusion of the regularly scheduled Board meeting on January 28, 2026.

Mr. Amar Maletira, a current member of the Board, has been appointed as the new Chair of the Audit Committee, effective upon Dr. Müller's resignation on January 28, 2026.

Mr. Maletira has over 25 years of extensive public company experience in business, strategy, and finance leadership within the enterprise technology sector. He has held various Chief Financial Officer roles, and the Board has determined he possesses the appropriate financial expertise for the Audit Committee Chair position.